Yi Li

机构：University of Science and Technology of China, Kunming Institute of Botany, Chinese Academy of Sciences, The Affiliated Yongchuan Hospital of Chongqing Medical University, General Hospital of Shenyang Military Region, First Affiliated Hospital of University of South China, Chongqing Medical University, University of South China · ORCID：0000-0002-7068-0019

发表论文 38 篇 · 总被引 814 次 · h-index 12

代表论文

• Mitomycin C induces pulmonary vascular endothelial‐to‐mesenchymal transition and pulmonary veno‐occlusive disease via Smad3‐dependent pathway in rats (2020 · British Journal of Pharmacology · 被引 41)
• Bitter taste receptor TAS2R14 activation and G protein assembly by an intracellular agonist (2024 · Cell Research · 被引 40)
• Altered Airway Microbiota Composition in Patients With Pulmonary Hypertension (2020 · Hypertension · 被引 40)
• STING agonist diABZI enhances the cytotoxicity of T cell towards cancer cells (2024 · Cell Death and Disease · 被引 37)
• Identification of an HLA‐A*24:02‐restricted α ‐fetoprotein signal peptide‐derived antigen and its specific T‐cell receptor for T‐cell immunotherapy (2019 · Immunology · 被引 18)
• Sodium tanshinone IIA sulfonate enhances the BMP9-BMPR2-Smad1/5/9 signaling pathway in rat pulmonary microvascular endothelial cells and human embryonic stem cell–derived endothelial cells (2022 · Biochemical Pharmacology · 被引 15)